January 27, 2026

Formulating for the Evolving GLP-1 Consumer

As the number of GLP-1 users continues to grow, it’s clear they are looking for more personalized, nutrient-dense food and beverage options to support their needs.

Close-up of woman eating omega 3 rich salad.

Kayt Sukel

Food Technology Magazine

Consumption Patterns

The rapid expansion of GLP-1 use is reshaping consumer eating patterns, driving demand for smaller, nutrient-dense, personalized food and beverage options.
Nutritional Requirements

GLP-1 users have evolving dietary needs—requiring higher protein, fiber, hydration, and targeted micronutrients—to manage side effects and maintain muscle and bone health during weight loss.
Market Segmentation

Because GLP-1 journeys vary widely, companies that tailor products to different user segments—and provide companion or maintenance offerings—will be best positioned in this emerging market.

The number of Americans taking anti-obesity medications continues to grow by leaps and bounds, especially the class of drugs known as glucagon-like peptide-1 (GLP-1) agonists. According to research organization RAND, nearly 12% of Americans have tried drugs like Ozempic (semaglutide) or Zepbound (tirzepatide), and notably, yet another 14% are interested in procuring their own prescription for a GLP-1 medication in the future.

These drugs work by targeting GLP-1, a satiety hormone that has been shown to support significant weight loss by quieting hunger signals in the brain while simultaneously slowing digestion.

Login or Sign Up To Continue

You’ve hit your limit of free articles. Either sign in to your existing account, or sign up to be an IFT member and get access to hundreds of digital resources and articlers.